Oakmark Equity and Income Fund added Molina Healthcare (MOH) to its portfolio, amplifying interest around MOH. The debate over its comparison with other
Health Care Services Stocks continues. Recently, it was
downgraded to Neutral by a Baird analyst, and some worry about its performance amidst market turmoil. Yet, others believe that it can thrive long-term. MOH's Q4 earnings reports were strong, with
premium revenue surging, but the company also faced increasing medical costs. Significantly, Molina was one of billionaire
Michael Burryβs top stock picks. Its stock dropped post Q4 report, initiating discussions on whether to buy, sell, or hold. The company has witnessed
strong full-year growth amidst Q4 challenges, furthering anticipation for its Q1 2025 results. Molina's acquisition of
ConnectiCare's member base marked a major development, while also winning an
exclusive Illinois contract and offering $750 million of 6.250% senior notes due 2033. News of insider entities buying sizable quantities of the stock further attracted investors. Despite some insiders selling high-valued stock,
price targets have been raised by Truist and Mizuho, indicating a positive outlook.
Molina Healthcare MOH News Analytics from Tue, 20 Aug 2024 07:00:00 GMT to Thu, 17 Apr 2025 20:55:50 GMT -
Rating 2
- Innovation -1
- Information 6
- Rumor 6
